• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases.

作者信息

Thankam Finosh G, Agrawal Devendra K

机构信息

Department of Translational Research, Western University of Health Sciences, Pomona, Calif.

Department of Translational Research, Western University of Health Sciences, Pomona, Calif.

出版信息

J Thorac Cardiovasc Surg. 2021 Feb;161(2):e217-e226. doi: 10.1016/j.jtcvs.2020.05.083. Epub 2020 Jun 6.

DOI:10.1016/j.jtcvs.2020.05.083
PMID:32631657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834736/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/ed80d01f8644/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/20c77ab016b3/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/045f7415f400/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/ec0da57cd520/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/ef75bef5e0a3/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/ed80d01f8644/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/20c77ab016b3/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/045f7415f400/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/ec0da57cd520/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/ef75bef5e0a3/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/7834736/ed80d01f8644/gr4_lrg.jpg

相似文献

1
Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases.2019冠状病毒病（COVID-19）合并心血管疾病患者细胞因子爆发的分子记录
J Thorac Cardiovasc Surg. 2021 Feb;161(2):e217-e226. doi: 10.1016/j.jtcvs.2020.05.083. Epub 2020 Jun 6.
2
SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.SARS-CoV-2 激活肺上皮细胞促炎信号，导致 COVID-19 患者免疫失调。
EBioMedicine. 2021 Aug;70:103500. doi: 10.1016/j.ebiom.2021.103500. Epub 2021 Jul 23.
3
IL-6 Induction and Signaling: Horizons of COVID-19-Related Pathogenesis.白细胞介素-6的诱导与信号传导：新冠病毒相关发病机制的研究前沿
DNA Cell Biol. 2021 May;40(5):639-642. doi: 10.1089/dna.2021.0152. Epub 2021 Apr 13.
4
SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）改变血脑屏障完整性，导致神经炎症。
J Neuroimmune Pharmacol. 2021 Mar;16(1):4-6. doi: 10.1007/s11481-020-09975-y. Epub 2021 Jan 6.
5
Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.将 ACE2 和血管紧张素 II 与 SARS-CoV-2 感染中的肺免疫血管失调联系起来。
Int J Infect Dis. 2020 Dec;101:42-45. doi: 10.1016/j.ijid.2020.09.041. Epub 2020 Sep 17.
6
Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.冠状病毒增加宿主细胞表面受体血管紧张素转化酶 2 的表达可能有助于 2019-nCoV（或 SARS-CoV-2）感染。
J Med Virol. 2020 Nov;92(11):2693-2701. doi: 10.1002/jmv.26139. Epub 2020 Jul 2.
7
Cardiovascular aspects of COVID-19.COVID-19 的心血管方面。
Swiss Med Wkly. 2020 Dec 31;150:w20417. doi: 10.4414/smw.2020.20417. eCollection 2020 Dec 14.
8
Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2.血管紧张素转化酶作为新型 SARS-CoV-2 的新免疫靶点。
Immunol Cell Biol. 2021 Feb;99(2):192-205. doi: 10.1111/imcb.12396. Epub 2020 Oct 7.
9
The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19.调节性 T 细胞在降低重症 COVID-19 患者心血管并发症方面的治疗潜力。
Life Sci. 2022 Apr 1;294:120392. doi: 10.1016/j.lfs.2022.120392. Epub 2022 Feb 8.
10
Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.评估血管紧张素转化酶 2 介导的 SARS-CoV-2 在物种间的进入。
J Biol Chem. 2021 Jan-Jun;296:100435. doi: 10.1016/j.jbc.2021.100435. Epub 2021 Feb 19.

引用本文的文献

1
Role of Gut Microbiota in Long COVID: Impact on Immune Function and Organ System Health.肠道微生物群在长期新冠中的作用：对免疫功能和器官系统健康的影响
Arch Microbiol Immunol. 2025;9(1):38-53. Epub 2025 Feb 4.
2
Strategies to Minimize Virus Transmission During Anesthesia Procedures in COVID-19 Patients.新冠肺炎患者麻醉过程中减少病毒传播的策略。
Anesth Crit Care. 2024;6(4):48-59. doi: 10.26502/acc.071. Epub 2024 Oct 23.
3
Distinguishing Swine Flu (H1N1) from COVID-19: Clinical, Virological, and Immunological Perspectives.从临床、病毒学和免疫学角度区分甲型H1N1流感与新型冠状病毒肺炎

本文引用的文献

1
Potential role of a disintegrin and metalloproteinase-17 (ADAM17) in age-associated ventricular remodeling of rats.解整合素金属蛋白酶17（ADAM17）在大鼠年龄相关性心室重构中的潜在作用。
RSC Adv. 2019 May 7;9(25):14321-14330. doi: 10.1039/c9ra01190k.
2
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
3
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Arch Microbiol Immunol. 2023;7(4):271-280. doi: 10.26502/ami.936500125. Epub 2023 Nov 3.
4
Thromboembolism in the Complications of Long COVID-19.新冠长期并发症中的血栓栓塞
Cardiol Cardiovasc Med. 2023;7(2):123-128. doi: 10.26502/fccm.92920317. Epub 2023 Apr 20.
5
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies.长期新冠：并发症、潜在机制及治疗策略
Arch Microbiol Immunol. 2023;7(2):36-61. Epub 2023 May 9.
6
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology.炎症小体：COVID-19 病理生理学地平线上的一颗冉冉升起的新星。
Front Immunol. 2023 May 12;14:1185233. doi: 10.3389/fimmu.2023.1185233. eCollection 2023.
7
Assessment of fear among the general public of Kerala, India, following a surge of COVID-19 cases.在印度喀拉拉邦新冠肺炎病例激增后，对该邦普通民众的恐惧情绪进行评估。
Med Int (Lond). 2022 Mar 15;2(2):9. doi: 10.3892/mi.2022.34. eCollection 2022 Mar-Apr.
8
Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics.肠道-大脑通讯在 COVID-19 中的作用：分子机制、介质、生物标志物和治疗方法。
Expert Rev Clin Immunol. 2022 Sep;18(9):947-960. doi: 10.1080/1744666X.2022.2105697. Epub 2022 Jul 28.
9
Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients.炎症小体激活诱导的高凝状态：对 COVID-19 患者心血管功能障碍的影响。
Cells. 2021 Apr 16;10(4):916. doi: 10.3390/cells10040916.
10
Commentary: Evolving understanding of coronavirus disease 2019: Molecular biology, immunology, and surgery.述评：对2019冠状病毒病的认识进展：分子生物学、免疫学与外科学
J Thorac Cardiovasc Surg. 2021 Feb;161(2):e228-e230. doi: 10.1016/j.jtcvs.2020.05.087. Epub 2020 Jun 6.
2019冠状病毒病（COVID-19）与心血管疾病：关于血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂对严重急性呼吸综合征冠状病毒2感染的发病和严重程度潜在影响的观点
J Am Heart Assoc. 2020 Apr 7;9(7):e016219. doi: 10.1161/JAHA.120.016219. Epub 2020 Apr 1.
4
Clinical Characteristics of Covid-19 in China.中国新冠肺炎的临床特征
N Engl J Med. 2020 May 7;382(19):1860. doi: 10.1056/NEJMc2005203. Epub 2020 Mar 27.
5
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
6
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.新冠肺炎住院患者中心脏损伤与死亡的相关性研究：中国武汉。
JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.
7
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
8
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病（COVID-19）疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
9
A Review of Coronavirus Disease-2019 (COVID-19).新型冠状病毒肺炎（COVID-19）概述。
Indian J Pediatr. 2020 Apr;87(4):281-286. doi: 10.1007/s12098-020-03263-6. Epub 2020 Mar 13.
10
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.九名孕妇感染 COVID-19 的临床特征和宫内垂直传播潜力：病历回顾性研究。
Lancet. 2020 Mar 7;395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3. Epub 2020 Feb 12.